Intermedius Genicular Nerve in the Treatment of Patients With Chondromalacia Patella
NCT ID: NCT05096520
Last Updated: 2021-10-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
46 participants
INTERVENTIONAL
2021-05-15
2022-07-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
radiofrequency group
the radiofrequency needle will be advanced percutaneously towards the intermedius genicular nerve on the periosteum of the distal femoral shaft region until bone contact is achieved. In addition to imaging the nerve with ultrasound, sensory stimulation at 50 Hz frequency will be applied with a threshold value less than 0.6 V in order to determine its position more accurately. In order to prevent the inactivation of the motor nerves, the relevant nerve will be tested for the absence of fasciculation in the region of the lower extremity compatible with the application with the stimulation with a frequency of 2.0 V and 2 Hz. Before the activation of the radiofrequency generator, an injection of 1 ml of 2% lidocaine will be made, then the radiofrequency electrode will be added to the needle and the temperature level at the tip of the electrode will be increased to 80 degrees for 2 minutes, the procedure will be performed for each genicular nerve.
radiofrequency
the radiofrequency needle will be advanced percutaneously towards the intermedius genicular nerve on the periosteum of the distal femoral shaft region until bone contact is achieved. In addition to imaging the nerve with ultrasound, sensory stimulation at 50 Hz frequency will be applied with a threshold value less than 0.6 V in order to determine its position more accurately. In order to prevent the inactivation of the motor nerves, the relevant nerve will be tested for the absence of fasciculation in the region of the lower extremity compatible with the application with the stimulation with a frequency of 2.0 V and 2 Hz. Before the activation of the Baylis brand radiofrequency generator, an injection of 1 ml of 2% lidocaine will be made, then the radiofrequency electrode will be added to the needle and the temperature level at the tip of the electrode will be increased to 80 degrees for 2 minutes, the procedure will be performed for each genicular nerve.
2% lidocaine
2% lidocaine
control group
The intermedius genicular nerve will be found under US guidance and the genicular nerve will be blocked by injecting 1 ml of 2% lidocaine.
control
The intermedius genicular nerve will be found under US guidance and the genicular nerve will be blocked by injecting 1 ml of 2% lidocaine.
2% lidocaine
2% lidocaine
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
radiofrequency
the radiofrequency needle will be advanced percutaneously towards the intermedius genicular nerve on the periosteum of the distal femoral shaft region until bone contact is achieved. In addition to imaging the nerve with ultrasound, sensory stimulation at 50 Hz frequency will be applied with a threshold value less than 0.6 V in order to determine its position more accurately. In order to prevent the inactivation of the motor nerves, the relevant nerve will be tested for the absence of fasciculation in the region of the lower extremity compatible with the application with the stimulation with a frequency of 2.0 V and 2 Hz. Before the activation of the Baylis brand radiofrequency generator, an injection of 1 ml of 2% lidocaine will be made, then the radiofrequency electrode will be added to the needle and the temperature level at the tip of the electrode will be increased to 80 degrees for 2 minutes, the procedure will be performed for each genicular nerve.
control
The intermedius genicular nerve will be found under US guidance and the genicular nerve will be blocked by injecting 1 ml of 2% lidocaine.
2% lidocaine
2% lidocaine
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of chondromalacia patella after physical examination and MR imaging
* Those whose symptoms persist for \>3 months
* Participating in the study voluntarily
Exclusion Criteria
* History of previous knee surgery
* To have received physical therapy from the knee area in the last 6 months
* Previous RF treatment or any therapeutic injection of the knee such as steroid, hyaluronic acid within 3 months
* Those with pain radiating from the waist or hip
* Patients with neuropathic pain
* History of tumor, infectious, psychiatric disease, bleeding diathesis
* History of knee trauma in the last 6 months
* Those with systemic diseases such as hepatitis, coagulopathy
* Patients with BMI \>40
* Finding a leg length difference
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Gaziler Physical Medicine and Rehabilitation Education and Research Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yasin Demir
Physical Medicine and Rehabilitation Specialist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Serdar KESİKBURUN, MD
Role: STUDY_DIRECTOR
SBU,Gaziler Physical Medicine and Rehabilitation Education and Research Hospital
Burak BAYIR, MD
Role: PRINCIPAL_INVESTIGATOR
SBU,Gaziler Physical Medicine and Rehabilitation Education and Research Hospital
Özlem KÖROĞLU, MD
Role: PRINCIPAL_INVESTIGATOR
SBU,Gaziler Physical Medicine and Rehabilitation Education and Research Hospital
Esra ÇELİK KARBANCIOĞLU, MD
Role: PRINCIPAL_INVESTIGATOR
SBU,Gaziler Physical Medicine and Rehabilitation Education and Research Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Gaziler Physical Medicine and Rehabilitation Education and Research Hospital
Ankara, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Burak BAYIR, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
19
Identifier Type: -
Identifier Source: org_study_id